About the Project. Prostate cancer is responsible for over 52,000 cancer diagnoses within the UK per annum, and is the most common cancer in males, accounting for 27% of all new cancer cases diagnosed within men in 2016-2017. Read more
Cancer stem cells are a small population of cells in tumours maintaining the tumorigenic capacity (1). They are featured as quiescent (i.e., dormant), in contrast to the majority of cancer cells that actively proliferate under the aberrant regulation. Read more
Lung cancer is the largest cause of cancer-related deaths in the UK and worldwide. While little progress has been made in long-term survival rates, we now have a good understanding of the genetic drivers raising the prospect of earlier diagnosis and more effective treatments. Read more
Breast cancer is the second most common cancer in women worldwide accounting for approximately 25 percent of all new cases of cancer in women. Read more
The Institute of Cancer Sciences is part of a national centre of excellence in the fight against cancer. We carry out a programme of world-class science directed at understanding the molecular changes that cause cancer. Read more
47% of cancer diagnoses in Europe are classified as ‘less common or rare’ (Public Health England, 2014). A rare cancer is a reportedly lonely diagnosis due to lengthy and complex care pathways which can be a barrier to meeting other patients and families. Read more
The development of potent and selective small molecules that mediate dose-dependent inhibition of a protein in its natural environment is essential to elucidate the role of such nominated target in normal and pathological settings [1]. Read more
This exciting funded PhD project, supervised by experienced clinical academics is based at Lancaster University and will research health services in North Lancashire and South Cumbria. Read more
About the Project. Breast cancer is responsible for over 300,000 cancer diagnoses within the UK per annum, and it is estimated that one in 7 women will develop breast cancer. Read more
Can a deep learning framework that accommodates complex cancer ‘omics data, such as gene-expression data, with clinical phenotypic data enhance our ability to predict cancer patient survival?. Read more
Bowel cancer is the 2nd most common cause of cancer-related deaths worldwide (CRUK statistics), mainly because many patients are diagnosed in later stages of disease where response to treatment is poor - only 10% of patients with advanced disease survive for 5 years. Read more
It is known that there is an exponential increase in the incidence of obesity, type 2 diabetes (T2D), and cancer particularly in recent decades. Read more
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Monthly chance to win one of ten £10 Amazon vouchers; winners will be notified every month.*
Access to our £6,000 scholarship competition
Get funding opportunities & application tips
Weekly advice, student stories and study fairs
*Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw.
Create your myFindAPhD account to add this PhD to your shortlist to register for this event
Due to your Facebook privacy settings, we were unable to create your account at this time. Please select another method to sign up.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
We were unable to log you in with your Google account at this time. If you have third-party cookies blocked, please enable them, refresh, and try again.
Continue with Facebook
Looking to list your PhD opportunities? Log in here.